Testing if radiation, hormone therapy, and docetaxel versus radiation and hormone therapy after prostectomy decreases cancer recurrence

April 09, 2017
GU002
Prostate Cancer
Brian Myre, MD
Edward Cancer Center - Naperville
Edward Cancer Center - Plainfield
Nancy Knowles Cancer Center - Elmhurst

To compare any good and bad effects of using docetaxel along with the radiation therapy and hormone suppression therapy to using radiation and hormone suppression therapy alone in men with a high chance of prostate cancer recurrence after surgically removing the prostate.

Sponsor: NRG Oncology

https://clinicaltrials.gov/ct2/show/NCT01230866

  • Over the age of 18
  • Adenocarcinoma of the prostate
  • Prostatectomy must have been performed within 1 year
  • Post-Op PSA is positive
  • No clinical or radiological evidence of metastatic disease
  • No prior radiotherapy to the region of the study cancer
  • No prior systemic chemotherapy for the study cancer
Lifetime
Accepting Participants
Interventional
II/III
Kathy Seymour, BSN
630-646-6075
630-646-6110
630-646-6072